Skip to Content

Elekta AB Class B EKTAF

Morningstar Rating
$7.19 +0.10 (1.41%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EKTAF is trading within a range we consider fairly valued.
Price
$7.18
Fair Value
$1.56
Uncertainty
Very High
1-Star Price
$82.30
5-Star Price
$9.56
Economic Moat
Qjtmm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EKTAF is a good fit for your portfolio.

Trading Information

Previous Close Price
$7.09
Day Range
$7.197.19
52-Week Range
$6.688.40
Bid/Ask
$7.00 / $7.35
Market Cap
$2.75 Bil
Volume/Avg
165 / 661

Key Statistics

Price/Earnings (Normalized)
18.25
Price/Sales
1.62
Dividend Yield (Trailing)
18.23%
Dividend Yield (Forward)
3.13%
Total Yield
18.23%

Company Profile

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Growth
Total Number of Employees
4,541

Competitors

Valuation

Metric
EKTAF
BDX
ISRG
Price/Earnings (Normalized)
18.2520.0266.86
Price/Book Value
2.962.7210.11
Price/Sales
1.623.5519.15
Price/Cash Flow
11.0021.2352.65
Price/Earnings
EKTAF
BDX
ISRG

Financial Strength

Metric
EKTAF
BDX
ISRG
Quick Ratio
0.800.463.91
Current Ratio
1.071.084.76
Interest Coverage
7.594.17
Quick Ratio
EKTAF
BDX
ISRG

Profitability

Metric
EKTAF
BDX
ISRG
Return on Assets (Normalized)
4.57%3.40%14.56%
Return on Equity (Normalized)
13.71%7.05%17.02%
Return on Invested Capital (Normalized)
9.60%5.04%15.43%
Return on Assets
EKTAF
BDX
ISRG
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncZrd$137.3 Bil
BDX
Becton Dickinson & CoRmkvyds$71.1 Bil
ALC
Alcon IncLnmnhd$39.4 Bil
CLPBY
Coloplast A/S ADRVjmv$29.5 Bil
RMD
ResMed IncTzvxx$27.1 Bil
WST
West Pharmaceutical Services IncQtqz$26.9 Bil
BAX
Baxter International IncWtjrs$21.6 Bil
COO
The Cooper Companies IncFpckg$19.2 Bil
HOLX
Hologic IncYppyqr$17.9 Bil
TFX
Teleflex IncBqd$11.2 Bil

Sponsor Center